Digital Health promises to revolutionize healthcare delivery, enable patient-centric medicine, and offer new tools for drug and diagnostic development. The applications of sensors, mobile devices and wearables, Internet of Things, apps and mobile health
platforms, artificial intelligence, and digital biomarkers are quickly expanding into all areas of patient monitoring and disease management, point-of-care diagnostics, clinical research, and digital therapeutics. Cambridge Healthtech Institute’s
2nd Annual Digital Health Tech conference program will bring together leading experts and thought leaders in digital health to discuss the latest technologies and implementation of digital tools into the practice of medicine, drug and diagnostic development,
and improving patient outcomes.
Final Agenda
Day 1 | Day 2 | Day 3 | Download Brochure
Sunday, March 1
2:00 - 5:00 pm Afternoon Short Courses*
*Separate registration required
5:30 - 8:30 Dinner Short Courses*
*Separate registration required
Monday, March 2
8:00 - 11:00 am Morning Short Courses*
*Separate registration required
10:30 Conference Program Registration Open
11:45 Organizer’s Opening Remarks
Julia Boguslavsky, Executive Director, Conferences, Cambridge Healthtech Institute
11:50 Chairperson’s Remarks
Thomas Kluz, MS, General Partner, dRx Capital; Head, Healthcare Investing, Qualcomm Ventures
11:55 KEYNOTE PRESENTATION: How Is Wearable-Driven Digital Health Shaping Non-Critical Care?
Ravi Kuppuraj,
PhD, CEO, Digital Innovator, Connected Sensing, Philips
Consumer wearable devices have already begun to reshape our general experience by putting people in the driver seat and back in charge of their healthcare – and now the healthcare industry has not only begun to see the same potential with
clinical wearables, but they are becoming more widely adopted and sought after to address real concerns, like providing increased mobility for patients and decreasing costs for healthcare systems in non-critical care settings.
12:15 pm KEYNOTE PRESENTATION: AI and Its Disruptive Implications for Healthcare
Chris Gough, General Manager, Health & Life Sciences, Intel Corporation
In this talk, we will explore the disruptive potential of AI for the healthcare industry. This will include market insights, real-world examples of deployments and use cases in healthcare from around the world, and practical guidance for how to
prepare your organization to take advantage of these capabilities.
12:35
Charles Mathews, Principal, ClearView Healthcare Partners
Digital health technology is not only fostering the development and deployment of novel tools that provide innovative clinical information and interventions but it is also raising questions about commercialization, reimbursement, and value creation.
In this session, we will discuss the unique ways in which digital health can be leveraged (e.g., prevention, disease management, therapeutic, etc.) and weigh the trade-offs between business models (e.g., payer reimbursed, B2B, etc.). We will
also provide insights into strategies that harness the unique nature of digital tools and create a virtuous cycle that fosters innovation.
12:55 KEYNOTE PANEL DISCUSSION: How Is “Big Tech” Implementing Digital Health?
Moderator: Thomas Kluz, MS, General Partner, dRx Capital; Head, Healthcare Investing, Qualcomm Ventures
Panelists: Chris Gough, General Manager, Health & Life Sciences, Intel Corporation
Ravi Kuppuraj, PhD, CEO, Digital Innovator, Connected Sensing, Philips
Charles Mathews, Principal, ClearView Healthcare Partners
Joe Ritchie, Chief Commercial Officer, SensoryData Corporation
1:30 Digital Health Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own
2:05 Session Break
2:30 Chairperson’s Remarks
Maryam Gholami, Vice President, Chief Product Officer, Digital Innovations, Providence Health & Services
2:35 Towards Deployment of AI into Healthcare
Rachael Callcut, MD, MSPH, Associate Professor, Surgery, Zuckerberg San Francisco General Hospital and Trauma Center; Director of Data Science and Program Director, Smarter Health Artificial Intelligence Initiative, University of California,
San Francisco
This talk will focus on the state of the profession in bringing AI applications into the inpatient clinical environment. Included will be a discussion of successes to date, challenges, and opportunities.
3:00 Future of AI and Voice in Healthcare through the Lens of a Health System Digital Innovation Team
Maryam Gholami, Vice President, Chief Product Officer, Digital Innovations, Providence Health & Services
It’s here and it’s now. The influence of machine learning, artificial intelligence and voice is quickly spreading across various industries that touch our daily lives. The impact on healthcare will be massive. We are at the beginning
of our journey of exploring the use cases and matching technology solutions that will bring access and convenience to consumers’ health and make caregiving easier. In this talk, we will share some of the exciting opportunities and challenges
we are currently working on within the Digital Innovation team at Providence Health & Services.
3:25 The Present and Future of Team Documentation: The Role of Patients, Families, and AI
Steven Lin, MD, Vice Chief, Technology Innovation, Medical Director, Stanford Family Medicine; Executive Director, Stanford Medical Scribe Fellowship, Stanford University School of Medicine
Professional burnout among U.S. medical providers has reached epidemic levels with dire consequences for patients, providers, health systems, and society. One key driver of burnout is the burden of clinical documentation in the electronic health
record, which has given rise to the scribe industry and the development of digital scribes powered by artificial intelligence (AI). This session explores the present and future of team documentation with a focus on the role of patients, families,
and AI.
3:50 Using AI to Manage Populations at Scale to Improve Outcomes, Adherence and Costs: Results, Challenges, Learnings and What’s Next
Ting Shih, MBA, MS, CEO & Founder, ClickMedix; MIT Fellow, Leaders for Global Operations
Artificial intelligence holds the promise of advancing healthcare through predictions and decision-support. Having worked across the globe over the past decade, we have developed various prediction models to help in diagnosis and treatment management.
In collaboration with Medicare Advantage provider, Brand New Day, we applied predictive models on its insured population and implemented intervention programs to improve health outcomes while decreasing costs. In this session, we will be sharing
lessons learned, challenges and results.
4:15 Q&A with the Speakers
4:25 Refreshment Break and Transition to Plenary Keynote
4:35 Welcome Remarks
Cindy Crowninshield, RDN, LDN, HHC, Executive Event Director, Cambridge Healthtech Institute
4:45 PLENARY KEYNOTE INTRODUCTION
Thomas Westerling-Bui, PhD, Senior Scientist, Regional Business Development, Aiforia
5:00 PLENARY KEYNOTE PRESENTATION: High-Performance Medicine
Eric Topol, MD, Founder and Director, Scripps Research Translational Institute (SRTI); Author, Deep Medicine: How Artificial
Intelligence Can Make Healthcare Human Again
6:00 Grand Opening Reception in the Exhibit Hall with Poster Viewing, Speed Networking, Book Signing, and Meetup Group
7:30 End of Day
Day 1 | Day 2 | Day 3 | Download Brochure
Tuesday, March 3
7:30 am Registration Open and Morning Coffee
8:00 Organizer’s Remarks
Julia Boguslavsky, Executive Director, Conferences, Cambridge Healthtech Institute
8:05 Chairperson’s Remarks
Geoff McCleary, Director, Digital Health & Therapeutics, PricewaterhouseCoopers
8:10 NEW KEYNOTE PRESENTATION: Digital Health Technologies for Mental Health
Yu-Feng (Yvonne) Chan, MD, PhD, Senior Director, Medical Affairs for Digital Medicine, Otsuka
We're in the midst of a mental health crisis in the US and worldwide, with 20% of US adults experiencing some form of mental illness and an acute shortage of mental health professionals results in severe unmet needs and high economic costs. Digital
health technologies may offer new options for mental health treatment. This talk explores whether this technology enhanced, multi-stakeholder, multi-disciplinary approach could help drive better patient outcomes.
8:30 KEYNOTE PRESENTATION: The Experimental Science behind Empowering Teams
Matt Lasmanis, Vice President, Technology, GlaxoSmithKline
How do you make large organizations more agile, customer-centric and flexible? There are myriad answers, and GSK is using their science focused approach to guide the way. Matt Lasmanis, VP of Pharma US Tech, is leading the transformation of the
GSK tech culture, empowering his teams to achieve outcomes with clarity over certainty. In the presentation, Matt will discuss: 1) leading experiment-driven, data and product-oriented teams and avoiding non-failure driven culture, 2) empowering
teams to make decisions closer to the ground, 3) shifting mindset of teams to be more agile and business-minded.
8:50 Making Personalized Healthcare a Reality: The Potential of Digital Health Technologies
Mary
Beattie, MD, MAS, Global Group Medical Director, Personalized Health Care,
Roche/Genentech
At Roche, we are working collaboratively to develop Digital Health solutions that aim to improve patient outcomes at each stage of the care continuum. I will discuss how these initiatives can enhance patient care, from early diagnosis to remote
monitoring. Digital Health solutions are central to our Personalized Healthcare vision.
9:10 KEYNOTE PANEL DISCUSSION: How Is “Big Pharma” Implementing Digital Health?
Moderator: Geoff McCleary, Director, Digital Health & Therapeutics, PricewaterhouseCoopers
Panelists:
Joris van Dam, PhD, Head, Digital Therapeutics, Novartis Institutes for BioMedical Research
Mary Beattie, MD, MAS, Global Group Medical Director, Personalized Health Care, Roche/Genentech
Yu-Feng (Yvonne) Chan, MD, PhD, Senior Director, Medical Affairs for Digital Medicine, Otsuka
9:40 Refreshment Break in the Exhibit Hall with Poster Viewing, Speed Networking, Book Signing, and Meetup Group
10:40 Chairperson’s Remarks
Christopher M. Hartshorn, PhD, Program Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health
10:45 Reading between the Lines to Reduce the ‘Last Mile’ Problem in Cancer Patient Care
Christopher M. Hartshorn, PhD, Program Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health
Cancer patients disconnected from resource intensive cancer centers face challenges beyond simply the disease they are dealing with. These patient populations include rural communities as well as populations who have access hindered via disability,
transportation or time. This ‘last mile’ problem of healthcare delivery is becoming more tractable than before with modern broadband connectivity and sensors. This talk will discuss efforts across NCI and NIH to help mitigate.
11:05 Use of an Implantable Sensor to Monitor Heart Failure
Nirav Dalal, Senior Director, Data Science & Analytics, Abbott
The CardioMEMS™ HF System is the first and only FDA-approved wireless heart failure (HF) monitor that has been proven to significantly reduce heart failure hospitalizations and improve quality of life in New York Heart Association (NYHA)
Class III patients who have been hospitalized for heart failure in the previous year. The CardioMEMS HF System is a safe, reliable way to help patients manage their heart failure. This talk will discuss technology, workflow, and clinical
impact.
11:25 Ingestible Sensors: A New Approach to Look at Digestive Disorders and Nutritional Balance
Chris van Hoof, PhD, Vice President, Connected Health Solutions, imec; Managing Director, OnePlanet Research Center
Digestive processes are hard to examine yet they determine our health and well-being on a daily basis. Ingestible sensors can make a huge difference by providing a more comprehensive and longitudinal measurement of key parameters. imec is
using its advanced chip technologies for developing ingestible sensors with the aim to measure the mechanical, chemical and electrical processes in the gut. This requires innovations in many areas: sensing, (remote) powering, and wireless
communications.
11:45 Digital Therapeutics Deliver Evidence of Results: The Example of DarioHealth
Olivier Jarry, Chief Commercial Officer & President, DarioHealth
Digital therapeutics is still a radically new approach in a traditionally conservative healthcare system. Holding DTx up to the same standards of clinically proven evidence as drugs and medical devices is indispensable to generate credibility
and trust. DarioHealth accumulates individual medical and lifestyle data every day from which it generates analyses for the user to take action and for their healthcare practitioners, as well as to inform the healthcare community.
12:05 pm A Connected Sensor Evaluation Framework: Validity, Usability, Security and Data Governance
Andrea Coravos, CEO & Co-Founder, Elektra Labs
In this talk, we will dive into use of connected sensor technologies (e.g., wearables and other biosensors) for a range of health services, such as collecting digital endpoints in clinical trials and remotely monitoring patients in clinical care. The adoption of these technologies poses five novel risks that currently exceed current abilities to evaluate and secure these products: (1) validation, (2) security practices, (3) data rights and governance, (4) utility and usability; and (5) economic feasibility.
12:35 Session Break
12:40 Digital Health Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own
1:20 Refreshment Break in the Exhibit Hall with Poster Viewing, Speed Networking, Book Signing, and Meetup Group
2:00 Breakout Discussions in the Exhibit Hall (please click here for details)
3:00 Transition to Conference Programs
3:15 Chairperson’s Remarks
Mike McSherry, CEO, Xealth
3:20 Empowering the Patient with Integrated Data
Ardy Arianpour, CEO & Co-Founder, Seqster
Precision medicine combines elements of bioinformatics, biomarker research, genomics, epigenomics, nutrigenomics, pharmacogenomics, and proteomics, along with considerations involving environment, lifestyle, and traditional medical data.
By putting patients at the center of their healthcare we are able to break down all the data silos and allow them to bring together all their EHR, DNA and fitness health data in one place. In order to get the best outcomes for precision
medicine we need to leverage a person-centric interoperability platform.
3:50 Ensuring Patient Safety in Virtual Care
Timothy Wright, Chief Strategy Officer, InTouch Health
As the healthcare industry continues to define and build the future of “digital health,” there’s foreboding risk to patient outcomes and safety. With the 21st Century Cures Act eliminating FDA oversight of EHRs and telehealth
devices, the stakes are high when marrying healthcare with technology, begging the question – where does digital stop and health begin? InTouch Health shares best practices for self-governance to help HIT companies and healthcare
providers avoid the pitfalls of racing into health tech without the right game plan.
4:20 Preparing for a Digital Health Avalanche
Mike McSherry, CEO, Xealth
How can health systems easily integrate digital health tools with their clinician workflow and IT systems, make sure only needed patient data is sent, which options are covered by payers and show data around which are actually helping
patients? Learn how major organizations are organizing their digital health programs and enabling clinicians to prescribe and monitor digital health care content, apps, devices, and services from within their EHR systems, driving provider
and patient engagement and utilization of a variety of digital health tools.
4:50 Spring Fling Celebration in the Exhibit Hall with Poster Viewing, Speed Networking, Book Signing, and Meetup Group
6:00 End of Day
6:30 - 9:30 Dinner Short Courses*
*Separate registration required
Day 1 | Day 2 | Day 3 | Download Brochure
Wednesday, March 4
6:45 am Registration Open
7:00 BREAKFAST PANEL DISCUSSION: The Time is NOW: Creating Meaningful Change for Women in the Workplace (Sponsorship Opportunity Available)
(please see Women in Science page for details)
Moderator: Robin Toft, Author of WE CAN, The Executive Woman’s Guide to Career Advancement; Founder and Chairman, Toft Group Executive Search
Panelists: Camille Samuels, MBA, Partner, Venrock
Paul Hastings, President and CEO, Nkarta Therapeutics, Inc
Teresa L. Wright, MD, Staff Physician, Medicine, San Francisco Veterans Administration
8:00 Chairperson’s Remarks
Asif Dhar, Chief Health Informatics Officer, Principal, Deloitte Consulting LLP
8:05 Human Machine Collaboration: Welcome to the Dyadarity
John Mattison, MD, Chief Medical Information Officer, Emeritus, Kaiser Permanente
How do we rethink the zero-sum thinking about humans vs. machines in the world of AI? Can we pivot to a human-machine collaboration rapidly enough to avoid severe consequences of human disintermediation? Threats and opportunities in the
emerging Dyadarity will be discussed.
8:30 Creating an Open Health Ecosystem
Claus Jensen, PhD, Chief Digital Officer and Head of Technology, Memorial Sloan Kettering Cancer Center
Most of us have personally experienced some aspect of disconnectedness as we journey through the health ecosystem - where data isn’t shared, conversation is not continued, or processes are disconnected. Join this session to discuss
how to create a more open and connected health ecosystem through technological means, from blockchain to emotional intelligent analytics.
8:55 Anticipating and Filling the Digital Gaps in Connected Care
Laura Yecies, Digital Health Entrepreneur, Advisor, RX.Health, Akili Interactive
Digital health and connected care offer the promise of dramatically altering healthcare and have begun to prove and grow their use. Yet for the industry to mature, we need to anticipate and fill the “digital gaps” that will
invariably emerge between individual products and across care delivery systems. This talk will discuss the noticeable gaps beginning to emerge, how to potentially fill them and work to proactively spot new ones.
9:20 Reimbursement for Digital Health Products: What Can We Learn from the Diagnostics Industry?
Mark Girardi, Vice President, Boston Healthcare
Previous coverage and reimbursement processes for diagnostic testing can provide valuable insights and the start of a blueprint for digital health products. In this session, we will review several key considerations and recommendations
for digital health companies and recommendations for digital health companies.
9:40 Refreshment Break in the Exhibit Hall with Poster Viewing, Speed Networking, Book Signing, and Meetup Group
10:40 Chairperson’s Remarks
Asif Dhar, Chief Health Informatics Officer, Principal, Deloitte Consulting LLP
10:45 KEYNOTE PRESENTATION: Harmonizing Healthcare Innovation for Better, Faster Transformation
Leigh Anderson, President of Performance Services, Premier, Inc.
Leigh Anderson, Premier’s President of Performance Services, will address the evolving healthcare ecosystem and how technological innovation including the application of artificial intelligence and machine learning must occur using
a collaborative framework in order to quickly meet our goals of providing more coordinated, patient-centric and high-quality care.
11:10 KEYNOTE PRESENTATION: Smart Health Communities
Asif Dhar, Chief Health Informatics Officer, Principal, Deloitte Consulting LLP
This presentation will cover how digital disruptions are going to completely change the way we live and empower communities to battle disease and create abundant wellness.
11:35 KEYNOTE PANEL DISCUSSION: Building Digital Healthcare
Moderator: Asif Dhar, Chief Health Informatics Officer, Principal, Deloitte Consulting LLP
Panelists: Leigh Anderson, President of Performance Services, Premier, Inc.
John Mattison, MD, Chief Medical Information Officer, emeritus, Kaiser Permanente
Claus Jensen, PhD, Chief Digital Officer & Head of Technology, Memorial Sloan Kettering Cancer Center
Laura Yecies, Digital Health Entrepreneur, Advisor, RX.Health, Akili Interactive
12:15 pm Session Break
12:50 Digital Health Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own
1:20 Refreshment Break in the Exhibit Hall with Last Chance Poster Viewing, Speed Networking, Book Signing, and Meetup Group
2:00 Chairperson’s Remarks
Adrian Chernoff, Former Worldwide Vice President, Global Head of Research and Development, Johnson and Johnson
2:05 Wearables and Health
Michael Snyder, PhD, Stanford W. Ascherman Professor & Chair, Department of Genetics; Director, Center for Genomics & Personalized Medicine, Stanford University
We have been using smart watches and continuous glucose monitoring to track people's health and find early signs of disease.
2:25 Patient-Centricity, the Future to Enabling Digital Health
Adrian Chernoff, Former Worldwide Vice President, Global Head of Research and Development, Johnson and Johnson
Payers, providers and patients are beginning to encounter changes to the healthcare landscape with the introduction of new digital tools. As we shift into this new reality a key component will be to put the patient at the center, shifting
the relationship dynamics in how we deliver digital applications and build digital ecosystems to meet the growing needs of patients at any stage of care from healthcare, home care of self-care.
2:45 The Power and Potential of VR Medicine
Ramsay Brown, Director, Product Science, AppliedVR
With over 30 years of clinical research, the healthcare industry has embraced virtual reality (VR). Today, rapidly advancing mobile technology yielding ever more immersive experiences at a lower cost, is driving the use of VR beyond research
environments into the clinical trenches and patient homes. Therapeutic VR is a promising new modality with the potential to treat serious and debilitating medical conditions, including pain – one of the most widely studied of
all disease areas to date – by delivering a low-risk, non-pharmacological intervention.
3:05 Virtual Worlds, Real Results: How VR Is Transforming Healthcare
Howard Rose, MEd, CEO & Co-Founder, Firsthand Technology
Howard will share the compelling evidence from clinical applications of VR therapy. VR’s potential to induce deep changes in the brain unlocks new therapies for challenging conditions and populations. Propelled by the tsunami of
consumer technologies, VR is poised to be the engine for personalized medicine that will fundamentally transform our health and the healthcare industry.
3:25 Close of Conference
Day 1 | Day 2 | Day 3 | Download Brochure